Shandong Pharmaceutical Glass Co Ltd (600529) — Cash Flow Reinvestment Rate
Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow Reinvestment Rate of 5.03x as of December 2025, reinvesting CN¥208.74 Million (capex CN¥153.18 Million plus investments CN¥55.56 Million) from operating cash flow of CN¥41.46 Million. Check Shandong Pharmaceutical Glass Co Ltd (600529) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Pharmaceutical Glass Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Shandong Pharmaceutical Glass Co Ltd across 24 annual periods. Explore Shandong Pharmaceutical Glass Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Shandong Pharmaceutical Glass Co Ltd. For live market cap and broader valuation context, see Shandong Pharmaceutical Glass Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥311.94 Million | CN¥576.92 Million | CN¥231.86 Million | ▼ -43.7% |
| 2024 | 0.96x | CN¥1.12 Billion | CN¥1.17 Billion | CN¥647.79 Million | ▼ -29.0% |
| 2023 | 1.35x | CN¥1.42 Billion | CN¥1.05 Billion | CN¥671.53 Million | ▼ -77.4% |
| 2022 | 5.97x | CN¥1.51 Billion | CN¥252.44 Million | CN¥710.71 Million | ▲ +407.1% |
| 2021 | 1.18x | CN¥883.26 Million | CN¥750.44 Million | CN¥809.26 Million | ▼ -12.9% |
| 2020 | 1.35x | CN¥765.20 Million | CN¥566.01 Million | CN¥535.20 Million | ▼ -11.9% |
| 2019 | 1.54x | CN¥919.69 Million | CN¥599.05 Million | CN¥591.69 Million | ▼ -1.7% |
| 2018 | 1.56x | CN¥727.38 Million | CN¥465.77 Million | CN¥347.38 Million | ▲ +32.0% |
| 2017 | 1.18x | CN¥487.24 Million | CN¥411.96 Million | CN¥167.06 Million | ▲ +102.9% |
| 2016 | 0.58x | CN¥295.25 Million | CN¥506.53 Million | CN¥196.58 Million | ▲ +22.7% |
| 2015 | 0.48x | CN¥185.12 Million | CN¥389.63 Million | CN¥155.12 Million | ▼ -5.1% |
| 2014 | 0.50x | CN¥133.53 Million | CN¥266.63 Million | CN¥133.53 Million | ▼ -10.6% |
| 2013 | 0.56x | CN¥150.49 Million | CN¥268.60 Million | CN¥150.49 Million | ▼ -86.9% |
| 2012 | 4.28x | CN¥122.10 Million | CN¥28.52 Million | CN¥122.10 Million | ▲ +440.5% |
| 2011 | 0.79x | CN¥217.53 Million | CN¥274.63 Million | CN¥217.53 Million | ▼ -14.2% |
| 2010 | 0.92x | CN¥200.37 Million | CN¥217.01 Million | CN¥200.37 Million | ▲ +94.3% |
| 2009 | 0.48x | CN¥118.44 Million | CN¥249.27 Million | CN¥118.44 Million | ▼ -72.5% |
| 2008 | 1.73x | CN¥158.40 Million | CN¥91.76 Million | CN¥158.40 Million | ▲ +31.6% |
| 2007 | 1.31x | CN¥160.82 Million | CN¥122.63 Million | CN¥160.82 Million | ▲ +45.8% |
| 2006 | 0.90x | CN¥70.59 Million | CN¥78.47 Million | CN¥70.59 Million | ▼ -53.4% |
| 2005 | 1.93x | CN¥85.09 Million | CN¥44.09 Million | CN¥85.09 Million | ▼ -57.8% |
| 2003 | 4.58x | CN¥271.74 Million | CN¥59.35 Million | CN¥271.74 Million | ▲ +344.7% |
| 2002 | 1.03x | CN¥112.49 Million | CN¥109.26 Million | CN¥112.49 Million | ▲ +16.3% |
| 2001 | 0.89x | CN¥25.32 Million | CN¥28.60 Million | CN¥25.32 Million | — |